Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

10.5%

2 terminated out of 19 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed with results

Key Signals

4 with results80% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (11)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (1)

Trial Status

Completed8
Recruiting6
Terminated2
Not Yet Recruiting2
Unknown1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT07454447RecruitingPrimary

UBM Evaluation After Combined Deep Sclerectomy With Trabeculotomy in Primary Open Angle Glaucoma

NCT07418853Not ApplicableNot Yet Recruiting

Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries

NCT07322965Not ApplicableRecruiting

Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma

NCT07335211Phase 3RecruitingPrimary

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT07147647Not ApplicableRecruitingPrimary

Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma

NCT07119905Not Yet RecruitingPrimary

Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patients in Sohag University Hospital

NCT06615661RecruitingPrimary

A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma

NCT06792422Phase 4RecruitingPrimary

A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma

NCT06016972Phase 2CompletedPrimary

Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients

NCT02434692Not ApplicableCompletedPrimary

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)

NCT06630546Not ApplicableCompletedPrimary

Trabecular Microbypass IStent in Patients with Glaucoma

NCT02700984Not ApplicableCompletedPrimary

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial

NCT03478293Not ApplicableTerminatedPrimary

iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

NCT01517477Not ApplicableCompletedPrimary

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

NCT01252849Not ApplicableCompletedPrimary

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

NCT01085357Not ApplicableCompletedPrimary

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery

NCT01166659Not ApplicableCompletedPrimary

Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy

NCT00902109UnknownPrimary

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients

NCT01180062Phase 1TerminatedPrimary

Safety Study of Latanoprost Slow Release Insert

Showing all 19 trials

Research Network

Activity Timeline